Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

125.17 -0.23 (-0.19%)
Streaming Delayed Price Updated: 1:22 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
50 51 Next >
News headline image
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits ↗
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt... 
Via Benzinga
Topics Lawsuit
News headline image
The 3 Best Healthcare Stocks to Buy in July 2024 ↗
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy. 
Via InvestorPlace
News headline image
AbbVie Stock: A Perfect Dip for Investors to Buy
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors 
Via MarketBeat
Topics ETFs
News headline image
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven ↗
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500. 
Via InvestorPlace
Topics Stocks
News headline image
7 Analysts Have This To Say About Abbott Laboratories ↗
 
Via Benzinga
News headline image
Market Whales and Their Recent Bets on ABT Options ↗
 
Via Benzinga
News headline image
Abbott Laboratories's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
3 MedTech Stocks to Buy for Healthy Gains ↗
With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy. 
Via InvestorPlace
News headline image
Stocks Going Ex Dividend In July 2024 ↗
This article features a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as... 
Via Talk Markets
News headline image
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income ↗
Buying dividend stocks for income is a smart investment strategy to juice your portfolio's returns even in down markets. 
Via InvestorPlace
News headline image
Top Analyst Reports For Abbott, BP & Gilead ↗
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and... 
Via Talk Markets
News headline image
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year ↗
The power of compounding can build huge amounts of passive income. 
Via The Motley Fool
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗
These healthcare players offer you dividends and a strong earnings picture. 
Via The Motley Fool
News headline image
2 Healthcare Stocks to Buy Hand Over Fist in June ↗
They both have pretty impressive pasts, and their prospects look just as bright. 
Via The Motley Fool
News headline image
2 Magnificent Dividend Growth Stocks to Buy Now ↗
These two dividend growth stocks are potent capital appreciation vehicles. 
Via The Motley Fool
News headline image
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom ↗
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device. 
Via Investor's Business Daily
News headline image
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court ↗
WuXi AppTec employees collaborated with China's PLA on altitude sickness drugs, raising national security concerns in the U.S. Congressional committee calls for restricting biotech ties amid ongoing... 
Via Benzinga
News headline image
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash ↗
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues ↗
NYSE experiences trading halts Monday due to a technical issue. Stocks like Berkshire Hathaway and Chipotle are impacted. 
Via Benzinga
News headline image
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals? ↗
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat. 
Via The Motley Fool
News headline image
The 3 Best MedTech Stocks to Buy Now: May 2024 ↗
Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024 ↗
Investors would be wise to pay attention to the analyst ratings on these leading healthcare stocks to buy, which are expected to rise. 
Via InvestorPlace
News headline image
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market ↗
With uncertainty clouding the market, investors can sleep a little easier at night with these reliable dividend stocks. 
Via InvestorPlace
News headline image
Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches ↗
The bull market momentum is unstoppable and these blue-chip stocks have the earnings growth to drive upside. 
Via InvestorPlace
News headline image
8 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:ABT),(NASDAQ:CELH),(NASDAQ:MNST),(NYSE:BRBR) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose ↗
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings. 
Via Benzinga
News headline image
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
From FN Media Group LLC
Via GlobeNewswire
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.